2 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow Locally Advanced Malignant Solid Neoplasm: new trials by email Literature Review of Locally Advanced Malignant Solid Neoplasm trials Research Report on Locally Advanced Malignant Solid Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer Antiretroviral Therapy, Biopsy, Biospecimen Collection - AIDS-Related Non-Hodgkin Lymphoma, Clinical Stage III Cutaneous Melanoma AJCC v8 | Phase 1 | Completed | National Cancer Institute (NCI) | 58 | 2016-04-04 | 2024-08-09 |
| Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer Biopsy, Biospecimen Collection, Computed Tomography - Hematopoietic and Lymphoid Cell Neoplasm, Locally Advanced Malignant Solid Neoplasm | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 27 | 2013-10-08 | 2025-01-14 |
Melanoma (2) · Neoplasm Metastasis (2) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · HIV Infections (1) · Hematologic Neoplasms (1) · Lung Neoplasms (1) · Lymphoma, Non-Hodgkin (1) · Neoplasms (1) · Recurrence (1) · Sarcoma, Kaposi (1)
Hemic and Lymphatic Diseases (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Nerve Tissue (2) · Neoplastic Processes (2) · Neuroectodermal Tumors (2) · Neuroendocrine Tumors (2) · Nevi and Melanomas (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Skin Diseases (2) · Skin Neoplasms (2) · Skin and Connective Tissue Diseases (2) · Adenocarcinoma (1)
Biopsy (2) · Magnetic Resonance Spectroscopy (2) · Specimen Handling (2) · Antiretroviral Therapy, Highly Active (1) · GSK2141795 (1) · dabrafenib (1) · pembrolizumab (1) · trametinib (1)
National Cancer Institute (NCI) (2)
United States (2)
Antoni Ribas (1) · Kathryn Lurain (1)
PMID 31154457, PMID 35080914, PMID 38261444, PMID 39356983, PMID 41680482
P30CA015704 (1), U01CA154967 (1), U10CA032102 (1), U10CA180830 (1), U10CA180888 (1)